Key facts
- This page summarizes Michael C. Skaff's Form 3 filing for Vivos Therapeutics, Inc. (VVOS).
- 0 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 20 Jun 2025, 17:54.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The Reporting Person serves as Managing Director of SP Manager LLC, the Manager of V-CO Investors LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F2
The Reporting Person serves as Managing Director of SP Manager LLC, the Manager of V-Co Investors 2 LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F3
The Pre-Funded Warrant has a term ending on the complete exercise of the Pre-Funded Warrant.